ARWR smart money
Arrowhead Pharmaceuticals, INC. (ARWR): 9 top funds holding it, 6 ETF changes in the public filings.
Top funds added, latest quarter$296M
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 24 | Orbimed Advisors LLC | BUY | 0.23% | $13M |
| 31 | Affinity Asset Advisors, LLC | ADD +183% | 1.62% | $28M |
| 50 | Siren, L.L.C. | ADD +34% | 3.55% | $150M |
| 63 | Vestal Point Capital, LP | ADD +206% | 8.14% | $315M |
| 71 | Baker Bros. Advisors LP | TRIM -14% | 0.53% | $112M |
| 74 | First Turn Management, LLC | BUY | 1.94% | $15M |
| 80 | Avoro Capital Advisors LLC | TRIM -3% | 7.43% | $720M |
| 86 | Adar1 Capital Management, LLC | 0.21% | $4M | |
| 96 | Pfm Health Sciences, LP | ADD +14% | 1.05% | $10M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| Invesco Dorsey Wright Momentum ETF | BUY | +$20M | 2026-07-31 |
| Invesco S&p Midcap Momentum ETF | ADD | +$18M | 2026-07-31 |
| Ishares U.S. Healthcare ETF | BUY | +$7M | 2026-07-31 |
| Alpha Architect U.S. Quantitative Momentum ETF | TRIM | −$1M | 2026-06-30 |
| Invesco S&p Midcap 400 Pure Growth ETF | TRIM | −$400k | 2026-07-31 |
| Nylim U.S. Large Cap R&d Leaders ETF | BUY | +$300k | 2026-07-31 |